Leukemia, Myelodysplasia, Transplantation
Conference Coverage
Can AML patients be too old for cell transplantation?
Opinion
The scope of under- and overtreatment in older adults with cancer
News
Two new protein biomarkers may serve as prognostic indicators for outcomes in CLL
Study also validated the prognostic value of two previously studied biomarkers.
Conference Coverage
Survey quantifies COVID-19’s impact on oncology
Oncologists detail how COVID-19 has impacted care, caregivers, continuing medical education, and clinical trials.
Article
COVID-19 prompts ‘democratization’ of cancer trials
Dr. Alan Lyss reviews a panel discussion about how COVID-19 has affected cancer research.
News
Oxidative stress linked to cytogenetic abnormalities in CLL
Article
Sequential Targeted Treatment of an Elderly Patient With Acute Myeloid Leukemia Harboring Concurrent FLT3-TKD and IDH1 Mutations: A Case Report
Article
Review of Efficacy and Safety Outcomes of Ibrutinib in a Veteran Population with Chronic Lymphocytic Leukemia
News
Aspirin may accelerate cancer progression in older adults
News
OK to treat many cancer patients despite pandemic, says ESMO
ESMO recommends against stopping or delaying cancer treatment that can impact survival.